Article

GLP-1 Receptor Agonist Improves Metabolic Disease in a Pre-clinical Model of Lipodystrophy

2023-09-05

Abstract excerpt

<h4>ABSTRACT</h4> Individuals with lipodystrophies typically suffer from significant metabolic disease linked to adipose tissue dysfunction including severe insulin resistance and lipoatrophic diabetes, hepatic steatosis and hyperphagia. Current treatment options are limited and beter therapies for affected individuals are urgently needed. No systematic, detailed analyses exist of the effects of glucagon like pep...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 84672d85-41bd-5f15-84d6-e7b9a6ebdc1d
DOI: 10.1101/2023.09.01.555852

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

GLP-1 Receptor Agonist Improves Metabolic Disease in a Pre-clinical Model of LipodystrophyDOI 10.1101/2023.09.01.555852Read

Seipin Deficiency as a Model of Severe Adipocyte Dysfunction: Lessons from Rodent Models and Teaching for Human Disease.Semantic proximity Read

Seipin ablation in mice results in severe generalized lipodystrophy.Semantic proximity Read

Mouse models of inherited lipodystrophy.Semantic proximity Read

Towards a mechanistic understanding of lipodystrophy and seipin functions.Semantic proximity Read

Lipodystrophy: metabolic insights from a rare disorderSemantic proximity Read

Tirzepatide for LipodystrophySemantic proximity Read

Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency.Semantic proximity Read

Knockout of murine <i>Lyplal1</i> confers sex-specific protection against diet-induced obesitySemantic proximity Read

Efficacy of leptin therapy in the different forms of human lipodystrophy.Semantic proximity Read

Tirzepatide but not Semaglutide Ameliorates Hepatic Steatosis and Inflammatory Infiltration in a Mouse Model of MASLD via Inhibition of the CCL2/CCR2-PI3K-Akt PathwaySemantic proximity Read

Phenotype-Directed Precision Therapeutics: A Framework for Multi-Agonist Therapy in Obesity, MASH and Cardio-Renal-Metabolic DisordersSemantic proximity Read

Phenotype-Directed Precision Therapeutics: A Framework for Multi-Agonist Therapy in Obesity, MASH and Cardio-Renal-Metabolic DisordersSemantic proximity Read